These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 23810883)

  • 41. Characterisation of patients referred to a tertiary-level inherited cardiac condition clinic with suspected arrhythmogenic right ventricular cardiomyopathy (ARVC).
    Aljehani A; Kew T; Baig S; Cox H; Sommerfeld LC; Ensam B; Kalla M; Steeds RP; Fabritz L
    BMC Cardiovasc Disord; 2023 Jan; 23(1):14. PubMed ID: 36635648
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of the T-wave characteristics on distinguishing arrhythmogenic right ventricular cardiomyopathy from healthy children.
    Imamura T; Sumitomo N; Muraji S; Yasuda K; Nishihara E; Iwamoto M; Tateno S; Doi S; Hata T; Kogaki S; Horigome H; Ohno S; Ichida F; Nagashima M; Makiyama T; Yoshinaga M
    Int J Cardiol; 2021 Jan; 323():168-174. PubMed ID: 32877757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The clinical analysis of plakophilin-2 gene mutation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia].
    Liu X; Liu W; Hu D; Zhang L; Zhu T; Li C; Qiu X; Li L; Guo C; Liu X; Wang L; Zheng H; Wang C; Diao Q; Shi D; Zhan P; Deng Y; Liu K; Wang Y; Liu B; Liu H; Qin X; Lan Y
    Zhonghua Nei Ke Za Zhi; 2015 Dec; 54(12):1001-6. PubMed ID: 26887364
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy.
    Protonotarios A; Anastasakis A; Panagiotakos DB; Antoniades L; Syrris P; Vouliotis A; Stefanadis C; Tsatsopoulou A; McKenna WJ; Protonotarios N
    Europace; 2016 Apr; 18(4):610-6. PubMed ID: 25825460
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Right Ventricular Imaging and Computer Simulation for Electromechanical Substrate Characterization in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Mast TP; Teske AJ; Walmsley J; van der Heijden JF; van Es R; Prinzen FW; Delhaas T; van Veen TA; Loh P; Doevendans PA; Cramer MJ; Lumens J
    J Am Coll Cardiol; 2016 Nov; 68(20):2185-2197. PubMed ID: 27855808
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic value of isoproterenol testing in arrhythmogenic right ventricular cardiomyopathy.
    Denis A; Sacher F; Derval N; Lim HS; Cochet H; Shah AJ; Daly M; Pillois X; Ramoul K; Komatsu Y; Zemmoura A; Amraoui S; Ritter P; Ploux S; Bordachar P; Hocini M; Jaïs P; Haïssaguerre M
    Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):590-7. PubMed ID: 24970294
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Electrocardiographic Features Differentiating Arrhythmogenic Right Ventricular Cardiomyopathy From an Athlete's Heart.
    Brosnan MJ; Te Riele ASJM; Bosman LP; Hoorntje ET; van den Berg MP; Hauer RNW; Flannery MD; Kalman JM; Prior DL; Tichnell C; Tandri H; Murray B; Calkins H; La Gerche A; James CA
    JACC Clin Electrophysiol; 2018 Dec; 4(12):1613-1625. PubMed ID: 30573127
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Body surface potential mapping detects early disease onset in plakophilin-2-pathogenic variant carriers.
    Kloosterman M; Boonstra MJ; Roudijk RW; Bourfiss M; van der Schaaf I; Velthuis BK; Eijsvogels TMH; Kirkels FP; van Dam PM; Loh P
    Europace; 2023 Jul; 25(7):. PubMed ID: 37433034
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac sympathetic dysfunction in genotyped patients with arrhythmogenic right ventricular cardiomyopathy and risk of recurrent ventricular tachyarrhythmias.
    Paul M; Wichter T; Kies P; Gerss J; Wollmann C; Rahbar K; Eckardt L; Breithardt G; Schober O; Schulze-Bahr E; Schäfers M
    J Nucl Med; 2011 Oct; 52(10):1559-65. PubMed ID: 21908389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis.
    Bosman LP; Sammani A; James CA; Cadrin-Tourigny J; Calkins H; van Tintelen JP; Hauer RNW; Asselbergs FW; Te Riele ASJM
    Heart Rhythm; 2018 Jul; 15(7):1097-1107. PubMed ID: 29408436
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy.
    Rigato I; Bauce B; Rampazzo A; Zorzi A; Pilichou K; Mazzotti E; Migliore F; Marra MP; Lorenzon A; De Bortoli M; Calore M; Nava A; Daliento L; Gregori D; Iliceto S; Thiene G; Basso C; Corrado D
    Circ Cardiovasc Genet; 2013 Dec; 6(6):533-42. PubMed ID: 24070718
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The precordial R' wave: A novel discriminator between cardiac sarcoidosis and arrhythmogenic right ventricular cardiomyopathy in patients presenting with ventricular tachycardia.
    Hoogendoorn JC; Venlet J; Out YNJ; Man S; Kumar S; Sramko M; Dechering DG; Nakajima I; Siontis KC; Watanabe M; Nakamura Y; Tedrow UB; Bogun F; Eckardt L; Peichl P; Stevenson WG; Zeppenfeld K
    Heart Rhythm; 2021 Sep; 18(9):1539-1547. PubMed ID: 33957319
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Arrhythmogenic response to isoproterenol testing vs. exercise testing in arrhythmogenic right ventricular cardiomyopathy patients.
    Denis A; Sacher F; Derval N; Martin R; Lim HS; Pambrun T; Massoullie G; Duchateau J; Cochet H; Pillois X; Cheniti G; Frontera A; Takigawa M; Vlachos K; Martin C; Kitamura T; Hocini M; Douard H; Jaïs P; Haïssaguerre M
    Europace; 2018 Jun; 20(FI1):f30-f36. PubMed ID: 29401235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical Characteristics and Follow-Up of Pediatric-Onset Arrhythmogenic Right Ventricular Cardiomyopathy.
    Roudijk RW; Verheul L; Bosman LP; Bourfiss M; Breur JMPJ; Slieker MG; Blank AC; Dooijes D; van der Heijden JF; van den Heuvel F; Clur SA; Udink Ten Cate FEA; van den Berg MP; Wilde AAM; Asselbergs FW; Peter van Tintelen J; Te Riele ASJM
    JACC Clin Electrophysiol; 2022 Mar; 8(3):306-318. PubMed ID: 35331425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epsilon Waves as an Extreme Form of Depolarization Delay: Focusing on the Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia.
    Platonov PG; Svensson A
    Curr Cardiol Rev; 2021; 17(1):17-23. PubMed ID: 32778035
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Arrhythmogenic Right Ventricular Cardiomyopathy: A Review of Living and Deceased Probands.
    Blusztein DI; Zentner D; Thompson T; Jayadeva P; Liang D; Wang R; Winship I; James PA; Trainer AH; Kalman JM; Vohra J
    Heart Lung Circ; 2019 Jul; 28(7):1034-1041. PubMed ID: 30126789
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update.
    Azaouagh A; Churzidse S; Konorza T; Erbel R
    Clin Res Cardiol; 2011 May; 100(5):383-94. PubMed ID: 21360243
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolated JUP plakoglobin gene mutation with left ventricular fibrosis in familial arrhythmogenic right ventricular cardiomyopathy.
    Zinkovsky D; Sood MR
    J Cardiovasc Electrophysiol; 2023 Oct; 34(10):2112-2121. PubMed ID: 37717241
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exercise restriction is protective for genotype-positive family members of arrhythmogenic right ventricular cardiomyopathy patients.
    Wang W; Tichnell C; Murray BA; Agafonova J; Cadrin-Tourigny J; Chelko S; Tandri H; Calkins H; James CA
    Europace; 2020 Aug; 22(8):1270-1278. PubMed ID: 32572458
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy.
    Syrris P; Ward D; Asimaki A; Sen-Chowdhry S; Ebrahim HY; Evans A; Hitomi N; Norman M; Pantazis A; Shaw AL; Elliott PM; McKenna WJ
    Circulation; 2006 Jan; 113(3):356-64. PubMed ID: 16415378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.